Balasa Dinverno & Foltz LLC Illumina, Inc. Transaction History

Balasa Dinverno & Foltz LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$209.2 - $335.53 $132,842 - $213,061	-635 Closed	0 $0
Q4 2019 Jan 22, 2020	BUY	$288.29 - $335.49 $183,064 - $213,036	635 New	635 $211,000
Q3 2019 Nov 06, 2019	SELL	$266.84 - $378.23 $165,974 - $235,259	-622 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$300.59 - $368.15 $186,966 - $228,989	622 New	622 $229,000
Q1 2019 May 10, 2019	SELL	$272.57 - $321.18 $196,522 - $231,570	-721 Closed	0 $0
Q4 2018 Feb 04, 2019	SELL	$272.46 - $366.54 $20,434 - $27,490	-75 Reduced 9.42%	721 $216,000
Q3 2018 Oct 24, 2018	BUY	$279.04 - $367.06 $222,115 - $292,179	796 New	796 $292,000

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.2B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.